Robert L Giuntoli

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medicine, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 23:869-76. 2013
  2. doi request reprint Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 22:273-9. 2012
  3. ncbi request reprint Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 106:82-8. 2007
  4. ncbi request reprint Evaluation and management of adnexal masses during pregnancy
    Robert L Giuntoli
    Hopkins Medical Institutions, Phipps 281, Baltimore, Maryland 21287, USA
    Clin Obstet Gynecol 49:492-505. 2006
  5. ncbi request reprint Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Anticancer Res 29:2875-84. 2009
  6. ncbi request reprint Uterine leiomyosarcoma: present management
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Curr Opin Oncol 16:324-7. 2004
  7. ncbi request reprint Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
  8. ncbi request reprint Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007
  9. doi request reprint Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
  10. ncbi request reprint Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007

Detail Information

Publications47

  1. doi request reprint Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medicine, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 23:869-76. 2013
    ..The aim of this study was to compare the accuracy of these 3 staging systems and a novel system in predicting disease-specific survival for patients with uterine LMS...
  2. doi request reprint Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 22:273-9. 2012
    ..The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC)...
  3. ncbi request reprint Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 106:82-8. 2007
    ..To identify effective treatment options for patients with recurrent uterine leiomyosarcoma (LMS)...
  4. ncbi request reprint Evaluation and management of adnexal masses during pregnancy
    Robert L Giuntoli
    Hopkins Medical Institutions, Phipps 281, Baltimore, Maryland 21287, USA
    Clin Obstet Gynecol 49:492-505. 2006
    ..In the approximately 5% of cases in which an adnexal masses proves to be a malignancy, appropriate staging may be safely performed. In selected cases, chemotherapy should at least be entertained...
  5. ncbi request reprint Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Anticancer Res 29:2875-84. 2009
    ..To identify immunosuppressive elements present in ovarian cancer associated ascites...
  6. ncbi request reprint Uterine leiomyosarcoma: present management
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Curr Opin Oncol 16:324-7. 2004
    ..To review current investigations impacting management of uterine leiomyosarcoma (LMS)...
  7. ncbi request reprint Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
    ..To evaluate the cost-effectiveness of intraperitoneal cisplatin and paclitaxel chemotherapy as front-line treatment for patients with Stage III epithelial ovarian cancer following optimal primary cytoreductive surgery...
  8. ncbi request reprint Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007
    ....
  9. doi request reprint Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
    ..To describe the operative technique and associated clinical outcomes of patients undergoing rectosigmoid colectomy as a component of secondary cytoreductive surgery for recurrent ovarian cancer...
  10. ncbi request reprint Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007
    ..The objective of this study was to evaluate the cost-effectiveness of centralized referral of patients with advanced-stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy...
  11. ncbi request reprint A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers
    Melissa A Gerardi
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 108:282-6. 2008
    ....
  12. doi request reprint Analysis of contemporary trends in access to high-volume ovarian cancer surgical care
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 16:3422-30. 2009
    ..However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined...
  13. doi request reprint Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics and Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 115:334-8. 2009
    ..To evaluate the impact of surgeon and hospital case volume, and other related variables, on short-term outcomes after surgery for ovarian cancer...
  14. ncbi request reprint Salvage cytoreductive surgery for recurrent endometrial cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 103:281-7. 2006
    ..To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with recurrent endometrial cancer...
  15. ncbi request reprint Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 103:709-13. 2006
    ..To examine the cost-effectiveness of routine vaginal cytology in detecting asymptomatic isolated vaginal recurrence during post-treatment endometrial cancer surveillance...
  16. ncbi request reprint Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe St Phipps 281, Baltimore, Maryland 21224, USA
    Ann Surg Oncol 14:3552-7. 2007
    ....
  17. pmc Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
    Stefanie M Ueda
    Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Am J Pathol 175:2618-24. 2009
    ..FASN inhibitors such as C93 warrant further investigation as targeted therapeutic agents for metastatic and chemoresistant gestational trophoblastic neoplasia...
  18. ncbi request reprint Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior
    Robert L Giuntoli
    Kelly Gynecologic Oncology Service, Johns Hopkins University, Baltimore, Maryland, USA
    J Reprod Med 52:1001-10. 2007
    ..To determine the prognostic accuracy of current diagnostic criteria for uterine smooth muscle tumors...
  19. doi request reprint Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 NorthWolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 109:364-9. 2008
    ..To describe the operative techniques and associated clinical outcomes of patients undergoing transverse colectomy as a component of cytoreductive surgery for advanced or recurrent ovarian cancer...
  20. ncbi request reprint Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
    Antonio Santillan
    Kelly Gynecology Oncology Service, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Oncol 23:9338-43. 2005
    ..To evaluate the risk of epithelial ovarian cancer (EOC) recurrence in patients with rising serum cancer antigen 125 (CA-125) levels that remain below the upper limit of normal (< 35 U/mL)...
  21. doi request reprint Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
    Shazia Bashir
    The Kelly Gynecology and Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 119:255-8. 2010
    ..To describe the technique and short-term post-operative outcomes associated with diaphragm full-thickness resection (FTR) and intraoperative trans-diaphragmatic decompression of the resultant pneumothorax (TDDP)...
  22. pmc Ascites specific inhibition of CD1d-mediated activation of natural killer T cells
    Tonya J Webb
    Department of Pathology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Clin Cancer Res 14:7652-8. 2008
    ..Given that ovarian cancer-associated ascites has been reported to have increased levels of gangliosides, we examined the effect of tumor-associated and other ascites on CD1d-mediated antigen presentation to NKT cells...
  23. ncbi request reprint Concentration of uterine cancer surgical care among the elderly: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 107:436-40. 2007
    ..To characterize the primary surgical care and short-term outcomes for uterine cancer in women age > or = 80 years compared to younger women...
  24. pmc Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer
    Tonya J Webb
    Department of Pathology and The Kelly Gynecologic Oncology Service, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21201, USA
    Cancer Res 72:3744-52. 2012
    ..These data therefore indicate that ovarian cancer tumors may use GD3 to inhibit the antitumor NKT cell response as an early mechanism of tumor immune evasion...
  25. doi request reprint Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Gynecol Oncol 109:388-93. 2008
    ..S. healthcare system of implementing a clinical pathway for Pap test utilization in screening and surveillance of gynecologic cancers in a university-based gynecologic oncology practice...
  26. ncbi request reprint Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 107:495-9. 2007
    ..To evaluate clinicopathological factors and survival outcome of patients with advanced epithelial ovarian carcinoma undergoing multiple bowel resections to achieve optimal (< or = 1 cm) cytoreduction...
  27. ncbi request reprint The role of cytoreductive surgery for colon cancer metastatic to the ovary
    Colleen C McCormick
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Gynecol Oncol 105:791-5. 2007
    ..We sought to further elucidate the survival impact of cytoreductive surgery among patients with colon cancer metastatic to the ovary...
  28. ncbi request reprint Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 104:739-46. 2007
    ....
  29. ncbi request reprint Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1043-7. 2006
    ..To characterize the patterns of primary surgical care and short term outcomes for uterine cancer according to surgeon and hospital case volume...
  30. doi request reprint Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Clin Imaging 34:191-5. 2010
    ..The objective of this study was to utilize computed tomographic peritoneography (CTP) to assess distribution prior to intraperitoneal chemotherapy for advanced müllerian cancer...
  31. doi request reprint Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
    Stephanie Ricci
    Johns Hopkins Hospital, Baltimore, MD, USA
    Gynecol Oncol 131:629-33. 2013
    ..To examine whether adjuvant therapy after primary surgery for treatment of early-stage uterine leiomyosarcoma (LMS) improves recurrence and survival rates...
  32. doi request reprint Evolution of a trophoblastic tumor from an endometrioid carcinoma--a morphological and molecular analysis
    Mathew T Olson
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Int J Gynecol Pathol 30:117-20. 2011
    ....
  33. pmc Comparison of candidate serologic markers for type I and type II ovarian cancer
    Dan Lu
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
    Gynecol Oncol 122:560-6. 2011
    ..To examine the value of individual and combinations of ovarian cancer associated blood biomarkers for the discrimination between plasma of patients with type I or II ovarian cancer and disease-free volunteers...
  34. ncbi request reprint Surgical care of elderly women with ovarian cancer: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 99:352-7. 2005
    ..To characterize the primary surgical care and short-term outcomes for ovarian cancer in women aged 80 years and older compared to women younger than 80 years...
  35. ncbi request reprint Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:294-300. 2005
    ..To evaluate the utility of combined positron emission tomography/computed tomography (PET/CT) for detecting recurrent epithelial ovarian cancer limited to retroperitoneal adenopathy...
  36. pmc A pilot study of surgical training using a virtual robotic surgery simulator
    Ana I Tergas
    Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    JSLS 17:219-26. 2013
    ....
  37. doi request reprint Importance and timing of end-of-life care discussions among gynecologic oncology patients
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Am J Hosp Palliat Care 30:59-67. 2013
    ..To assess the importance and desired timing of end-of-life care (EOLC) discussions among women with gynecologic cancer...
  38. pmc Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats
    Allison C Sharrow
    The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Ovarian Res 3:9. 2010
    ..Limited progress has been made toward improving the survival rate of patients with this disease in part because of the lack of a good animal model. We present here a model of spontaneous ovarian carcinoma arising in a normal Lewis rat...
  39. ncbi request reprint Artificial antigen-presenting cells: artificial solutions for real diseases
    Mathias Oelke
    Department of Pathology and Medicine, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Trends Mol Med 11:412-20. 2005
    ..These new approaches have the potential to spearhead a new era of successful adoptive immunotherapy for cancer and infectious diseases...
  40. pmc Volume-Based Care among Young Women Diagnosed with Uterine Cancer
    Teresa P Diaz-Montes
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    ISRN Surg 2011:541461. 2011
    ..00). Women ≤50 years managed at high-volume centers had higher adjusted cost of hospital-related care (P = 0.01). Conclusion. Primary surgical care of young women with uterine cancer is often performed by low-volume providers...
  41. ncbi request reprint Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma
    Yu Chi Chen
    Department of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Biochim Biophys Acta 1730:96-102. 2005
    ..001). In conclusion, these findings represent the first characterization of human membralin and suggest that membralin is a novel tumor-associated marker in ovarian serous carcinomas...
  42. ncbi request reprint A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
    Kathleen N Moore
    University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd WP 2470, Oklahoma City, OK 73014, and Washington University Barnes Jewish Christian Hospitals, St Louis, MO, USA
    Gynecol Oncol 105:299-303. 2007
    ..The objective of this study was to compare response rate and survival in patients with cervical cancer treated with PT or CT...
  43. ncbi request reprint Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy
    Robert L Giuntoli
    Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Gynecol Oncol 89:460-9. 2003
    ..We evaluated the predictive value of several proposed prognostic indicators and the effect of surgical management and adjuvant therapy on clinical outcome associated with leiomyosarcoma (LMS) of the uterus...
  44. ncbi request reprint Ovarian preservation in stage I low-grade endometrial stromal sarcomas
    Andrew J Li
    Department of Obstetrics Gynecology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Obstet Gynecol 106:1304-8. 2005
    ..To examine the impact of ovarian preservation in a case-control study of women with stage I low-grade endometrial stromal sarcomas...
  45. ncbi request reprint Frequent loss of pRb2/p130 in human ovarian carcinoma
    Giuseppina D'Andrilli
    Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA
    Clin Cancer Res 10:3098-103. 2004
    ..2, a region in which deletions have been found in several human neoplasms including breast, prostatic, and ovarian carcinoma. We sought to evaluate pRb2/p130 protein expression and function in ovarian carcinoma...
  46. ncbi request reprint Frozen section evaluation of cervical cold knife cone specimens is accurate in the diagnosis of microinvasive squamous cell carcinoma
    Robert L Giuntoli
    Division of Gynecologic Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Gynecol Oncol 91:280-4. 2003
    ..The purpose of this study was to determine the accuracy of frozen section evaluation of cervical cold knife cone (CKC) specimens in the diagnosis of microinvasive squamous cell carcinoma (SCC)...
  47. ncbi request reprint TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk
    Bobbie S Gostout
    Section of Gynecologic Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Gynecol Oncol 88:326-32. 2003
    ..We evaluated immune response genes in the HLA region of chromosome 6 to see if individual or interactive associations with cervical cancer risk could be identified...